Case Study: GLP-1 Medication Research Study
Tekton met enrollment goals for a GLP-1 study in Moore, OK three months early, with a one-day regulatory turnaround.
Tekton met enrollment goals for a GLP-1 study in Moore, OK three months early, with a one-day regulatory turnaround.
Tekton delivered a Phase 2 migraine study in Yukon, OK with 100% patient retention and a 1.5-day regulatory turnaround.
Growth supports Tekton’s strategic focus on CNS and Cardiometabolic research AUSTIN, TX – September 26, 2025 — Tekton Research, a leading multi-site clinical trial company, is proud to announce the addition of three new sites, five new Principal Investigators (PIs), and a renowned CNS Consultant to its expanding network. These additions reflect Tekton’s continued commitment … Read more
When it comes to clinical research, no two studies are exactly alike—but rare disease trials stand in a category of their own. Though each condition may affect only a small number of people, together rare diseases impact an estimated 300 million patients worldwide. For these individuals and families, research often represents the only pathway to … Read more
Alzheimer’s Disease remains one of the most pressing public health challenges of our time. Affecting over 6 million Americans, this progressive neurological disorder not only takes a profound toll on individuals and their families–it also places a significant burden on healthcare systems worldwide. While there is no cure yet, hope is on the horizon–and clinical … Read more
Obesity is more than a number on a scale–it’s a chronic disease that significantly increases the risk of developing long-term health conditions. At Tekton Research, we’re committed to advancing research in obesity because we know it’s at the core of a larger health crisis. Understanding and treating obesity isn’t just about weight loss, it’s about … Read more
From continuous glucose monitors to heart rate sensors, the tools patients use to monitor their health have never been more advanced—or more essential. At Tekton, we’re proud to conduct clinical trials for diagnostic devices and health technology that help shape the future of care. Whether it’s validating a new temperature thermometer, testing a next-generation continuous … Read more
Tekton achieved an average of 172% enrollment across three sites, enrolling more than 30 patients in a recent Type 1 Diabetes clinical trial.
Clinical trials are essential to advancing medicine, bringing new therapies from discovery to approval. Traditionally, these trials have been centered in academic institutions and large hospitals—but embedded research site networks like Tekton help make trials accessible within community-based settings, where patients are being treated every day. As a trusted partner in clinical research, Tekton makes … Read more
Initial Collaboration Launches at Yukon, OK Site Austin, TX — July 1, 2025 – Tekton Research is proud to announce a new strategic partnership with Summit Clinical Research, a leading Integrated Research Organization focused on solving the challenges of MASH/NASH clinical trials. The collaboration marks Tekton’s entry into MASH (Metabolic dysfunction-associated steatohepatitis) research, further expanding … Read more